PACLITAXEL - AN OVERVIEW

In September 2001, Good proposed paclitaxel to the treatment of Highly developed breast cancer once the failure of anthracyclic chemotherapy, but that its very first-line use really should be restricted to medical trials. In September 2006, NICE recommended paclitaxel should not be Employed in the adjuvant treatment of early node-positive breast ca